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Summary: Accurate estimation of HIV incidence rates is crucial for the monitoring of HIV epidemics, the evaluation
of prevention programs, and the design of prevention studies. Traditional cohort approaches to measure HIV incidence
require repeatedly testing large cohorts of HIV uninfected individuals with a HIV diagnostic test (e.g., enzyme-linked
immunosorbent assay) for long periods of time to identify new infections, which can be prohibitively costly, time-
consuming, and subject to loss to follow-up. Cross-sectional approaches based on the usual HIV diagnostic test and
biomarkers of recent infection offer important advantages over standard cohort approaches, in terms of time, cost, and
attrition. Cross-sectional sample usually consists of samples from different communities. However, small sample sizes
limit the ability to estimate community-specific incidences and existing methods typically ignore heterogeneity in
incidence across communities. We propose a permutation test for the null hypothesis of no heterogeneity in incidence
rates across communities, develop a random effects model to account for this heterogeneity and to estimate community-
specific incidences, and provide one way to estimate the coefficient of variation. We evaluate the performance of the
proposed methods through simulation studies and apply the proposed methods to the data from the National Institute
of Mental Health Project ACCEPT, a phase III randomized controlled HIV prevention trial in Sub-Saharan Africa,
to estimate the overall and community-specific HIV incidence rates.
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1. Introduction
Accurate estimation of HIV incidence rates is crucial for the monitoring of local HIV epi-
demics, the evaluation of the impact of prevention programs, and the design of prevention
studies. Traditional approaches to measure HIV incidence require repeatedly testing large
cohorts of HIV uninfected individuals with a HIV diagnostic test [e.g., enzyme-linked im-
munosorbent assay (ELISA)] for long periods of time to identify new infections, which can
be prohibitively costly and time-consuming. Such studies are also subject to differential loss
to follow-up and behavioral modification. An alternative approach entails biomarkers of HIV
disease progression that can distinguish recent from long-term infections (Brookmeyer and
Quinn, 1995). In this strategy, subjects are administered the usual HIV diagnostic test (e.g.,
ELISA); then, those found to be positive are tested with biomarkers associated with recent
infection (e.g., HIV-1 limiting antigen avidity enzyme immunoassay). The incidence estimate
is obtained by carefully combining results from the two tests and external information
about the average time individuals appear to be “recently infected”. This approach allows
investigators to estimate incidence by testing blood samples at a single point in time, can
provide quick and inexpensive estimates of HIV incidence rates and “may lead to a revolution
in the way that worldwide HIV epidemics are routinely tracked” (Hallett, 2011).
Cross-sectional surveys usually consist of samples from multiple communities with varying
HIV incidence rates. However, standard methods typically assume that the cross-sectional
sample is a random sample of the population of interest. That is, observations on individuals
in the sample are assumed to be independent. When the cross-sectional sample consists
of individuals from multiple communities, this independence assumption is likely to be
violated because observations on individuals in the same community are usually correlated.
This within-cluster correlation results from variability in the underlying community-specific
incidences. If there is heterogeneity in incidence across communities, then individuals in
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the same community will tend to have responses that are more similar to each other than
responses of individuals in different communities. Therefore, for clustered data, between-
cluster variability and within-cluster correlation provide two different perspectives on the
same underlying phenomenon. When analyzing clustered data, one must account for the
between-cluster variability (or within-cluster correlation). Ignoring this correlation may lead
to biased inference. To illustrate, we present a contour plot of the actual coverage of 95%
confidence intervals for the overall incidence across 30 communities when heterogeneity
is ignored, for varying magnitude of incidences and the heterogeneity across communities
(Figure 1; Details in the Web Appendix A). As shown in Figure 1, the actual coverage of
95% confidence intervals obtained ignoring the heterogeneity can be substantially lower than
the nominal level in many settings.
[Figure 1 about here.]
Furthermore, when incidence rates vary across communities, it would be useful to ob-
tain community-specific incidences and to quantify the heterogeneity in incidence rates
across communities. Small sample sizes and low incidence rates limit the ability to estimate
community-specific incidences. For example, in the baseline survey of the Botswana Com-
bination Prevention Project (BCPP), a cluster randomized trial involving 30 communities
in Botswana designed to evaluate the effectiveness and cost-effectiveness of a combination
prevention package (BCPP, 2013), among 30 communities, no individuals (among 70 to 150
individuals tested in each community) were identified as recent infections by the incidence
assay in 8 communities. A direct application of the existing formula would lead to an inci-
dence estimate of 0 in these communities. In this paper, we propose methods that can produce
improved community-specific incidence estimates. We also propose a permutation test for the
null hypothesis that there is no heterogeneity in incidence rates across communities. A test
for heterogeneity is indicative of whether or not substantial heterogeneity across communities
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exists. The proposed permutation test is easy to implement and its validity does not rely on
parametric assumptions.
Another purpose of this paper is to propose an estimator for the coefficient of variation
(CV) based on cross-sectional data. The CV captures the heterogeneity in outcomes across
communities and provides equivalent information regarding variance inflation as the intr-
aclass correlation coefficient (ICC) as described above. The statistical power of a cluster
randomized trial can change substantially depending on the CV. As we noted in designing
the BCPP, for a matched-pair cluster randomized trial with 15 pairs and a sample size of 300
within each community, the power to detect a 40% reduction in 3-year cumulative incidence
from 2.5% to 1.5% decreases from 80% to 52% as CV increases from 0.20 to 0.45 (i.e., an
increase in the ICC from 0.001 to 0.005). Obtaining accurate information on the CV is often
a major stumbling block in cluster randomized trials (Rutterford et al., 2015). Methods
to estimate the CV for HIV incidence based on cross-sectional data at baseline provide a
practical way to obtain this essential information for the design of cluster randomized trials.
The rest of the paper is organized as follows. In Section 2, we propose a random effects
model to account for heterogeneity of incidence rates across communities and to estimate
community-specific incidences, develop a permutation test for the null hypothesis of no
heterogeneity across community-specific incidences, and propose an estimator of the CV
for HIV incidence. In Section 3, we present results from simulation studies. In Section 4,
we apply the proposed methods to data from the NIMH Project ACCEPT to estimate the
overall and community-specific incidence rates. We conclude with discussions in Section 5.
2. Methods
2.1 Notation and Background
Suppose that N subjects are randomly selected from an asymptomatic population, and each
is tested with an ELISA and, if positive, tested with biomarkers of recent infection. We
https://biostats.bepress.com/harvardbiostat/paper213
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consider the three-state longitudinal natural history model (S-Figure 1(a); Web Appendix
B) of HIV seroconversion and subsequent reactivity to biomarkers of recent infection as in
Wang and Lagakos (2009): State 1 represents the pre-seroconversion state (uninfected or
infected but not seroconverted); State 2 represents the “recent infection” state, in which
an infected individual is identified as a “recent infection” by the biomarker; and State 3
represents the “long-term infection” state in which an infected individual is classified as a
“non-recent infection” by the biomarker. Let N1, N2, and N3 denote the number of subjects
who test negative on both tests (State 1), positive for both the diagnostic test and biomarkers
of recent infection (State 2), and positive for the diagnostic test but negative for biomarkers
of recent infection (State 3), respectively, so that N = N1+N2+N3. The actual time spent
in State 2 varies from person to person and is assumed to be independent of the time of
seroconversion. We use µ, commonly termed as the “mean window period”, to denote the
mean population time in State 2. Let λ and 1−φ denote the incidence rate and the prevalence
of long-term infection at the time of the cross-sectional sample.
In the setting of one population of interest, Balasubramanian and Lagakos (2010) and
Wang and Lagakos (2010) proposed a likelihood-based approach and derived the probability
of an individual falling into one of the three states (uninfected, recent infection and long-
term infection). The likelihoods considered in these earlier work are especially suited for
settings where the incidence is low. Here we consider a modification of the likelihood that
is more general and can also accommodate settings where the incidence is large. Let p1, p2,
and p3 denote the prevalence probabilities in State 1, 2, and 3, respectively, it follows that
p1 = φ − φµλ, p2 = φµλ, and p3 = 1 − φ. Note that (N1, N2, N3) follows a multinomial
distribution with parameters (p1, p2, p3). Therefore, the likelihood function for (φ, λ) based
on (N1, N2, N3) is given by
L(φ, λ) ∝ (φ− φµλ)N1(φµλ)N2(1− φ)N3. (1)
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The maximum likelihood estimators of (φ, λ) can be obtained by maximizing L(φ, λ), re-
sulting in φ̂ = (N1 + N2)/N , and λ̂ = N2/{(N1 +N2)µ}. To compute the estimators above,
N1, N2, and N3 are obtained from the cross-sectional sample, and µ is typically assumed
to be known. Estimators for the variances of (φ̂, λ̂) can be derived from the sample Fisher
information: V̂ar(φ̂) = N3(N1 +N2)/N
3, and V̂ar(λ̂) = N1N2/{(N1 +N2)3µ2}.
2.2 Random Effects Model
Suppose there are M communities. Let λi be the true community-specific incidence in
community i, for i = 1, . . . ,M. Let N1i, N2i, N3i, and Ni denote the number of subjects
in State 1, 2, 3, and the total number of subjects in community i, respectively.
2.2.1 Fixed Effects Model vs. Random Effects Model. Analogous to meta-analysis, here
we discuss the concept of a fixed effects model and a random effects model in the setting of
cross-sectional incidence estimation. Under the fixed effects model, we assume all commu-
nities have a common incidence rate λ∗, that is, λi = λ
∗, for i = 1, . . . ,M. The observed
incidence rates λ̂i are distributed around λ
∗, and each of λ̂i estimates the same underlying
incidence rate λ∗. The difference in observed incidences can be attributed purely to random
sampling error, which depends primarily on the size of the cross-sectional sample within
each community. The overall incidence based on the fixed effects model can be estimated by
λ̂∗ =
∑M
i=1N2i/
{(∑M
i=1N1i+
∑M
i=1N2i
)
µ
}
, and the corresponding variance can be estimated
by V̂ar(λ̂∗) =
∑M
i=1N1i
∑M
i=1N2i/
{(∑M
i=1N1i +
∑M
i=1N2i
)3
µ2
}
.
When the cross-sectional sample consists of subjects from various communities, and many
factors can lead to variations in incidence rates across different communities, the assumption
underlying the fixed effects model that incidence rates are the same is likely to be violated.
This motivated us to consider a more flexible random effects model to account for the
heterogeneity of incidence rates across communities. Here we assume community-specific
incidence rates differ by community and are a random sample drawn from a distribution. In
https://biostats.bepress.com/harvardbiostat/paper213
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this case, we consider the overall incidence as the mean of the random effects distribution,
that is, E(λi) = λ
∗, and Var(λi) = τ
2, where τ 2 denotes the between-community variability
in true incidence rates. Under the random effects model, the variability of the observed
incidence rates λ̂i results from both the within-community sampling error and the variation
of true underlying incidence rates λi across communities.
2.2.2 Random Effects Model Formulation. Suppose that λi follow a Lognormal distribu-
tion and let λi = λe
vi, where vi
i.i.d∼ N(0, σ2). We assume that data from M communities are
independent and data from individuals in the same community are conditionally independent
given vi. Under this Lognormal random effects model, the overall incidence, λ
∗ = λeσ
2/2, and
the between-community standard deviation of incidence, τ = λeσ
2/2
√
eσ2 − 1. Following (1),
the conditional likelihood of community i is given by:
Li(φ, λ|vi) ∝ (φ− φµλevi)N1i(φµλevi)N2i(1− φ)N3i, (2)
and the marginal likelihood can be obtained by integrating over the random effects:
L(φ, λ, σ2) =
M∏
i=1
∫
vi
Li(φ, λ|vi)f(vi|σ2)dvi
∝
M∏
i=1
∫
vi
{
(φ− φµλevi)N1i(φµλevi)N2i(1− φ)N3i × 1
σ
exp
(
− vi
2
2σ2
)}
dvi.
(3)
There is no closed form solution for this integral. We will approximate this integral using
numerical methods and then obtain the maximum likelihood estimators of (φ, λ, σ2) through
the maximization of the approximated marginal likelihood.
Community-specific incidences λi can be estimated based on the empirical Bayes estimates
of the random effects vi. Unlike the standard community-specific incidence estimates, which
can be calculated based on λ̂i = N2i/{(N1i + N2i)µ} using the observations from that
community only, information is “borrowed” across communities under the proposed random
effects model: the estimated community-specific incidences depend both on observations
from that community and observations from other communities, such that the estimate
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for each community is shrunk towards the overall incidence. This shrinkage effect is more
pronounced for smaller communities and communities whose within-community variability
is large relative to the between-community variability. The random effects model may lead
to more efficient community-specific incidence estimates, and is especially useful in the HIV
setting where the incidence is low and one single community usually has small sample size.
2.2.3 Four-state Random Effects Model to Incorporate the False Recency Rate. It has
been noted that some infected individuals can repeatedly test positive for biomarkers of
recent infection long after seroconversion (Novitsky et al., 2009; Claggett et al., 2012). In
this case, the underlying assumption of the three-state model is violated, and the resulting
incidence estimator is biased upwards by overestimating the number of subjects who are
recently infected. Here we present an extension of the random effects model to accommodate
this. Let 1−p, commonly termed as the “false recency rate”, denote the proportion of subjects
who would be tested as “recently infected” permanently in the HIV positive population. We
highlight the importance of an accurate estimate of the false recency rate in order to estimate
HIV incidence accurately. The estimation of p requires additional external information. This
may be done via an augmented design where the cross-sectional sample is augmented with a
longitudinal component (Wang and Lagakos, 2010), or by testing an independent sample of
individuals with known long-term infection from the same population (Moyo et al., 2014).
We consider the four-state model as in Wang and Lagakos (2009) (S-Figure 1(b); Web
Appendix B). State 1 and State 3 are defined the same way as in the three-state model, but
we distinguish subjects being tested as recent infections into those who would eventually
be classified as “long-term infected” (State 2) and those who would remain as “recently
infected” indefinitely (State 4). N1 and N3 still represent the number of subjects in State 1
and State 3, but now N2 represents the total number of subjects in either State 2 or State
4. The three-state model is a special case of the four-state model (p = 1).
https://biostats.bepress.com/harvardbiostat/paper213
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The conditional likelihood of community i in (2) now generalizes to:
Li(φ, λ|vi) ∝ (φ− φµλevi)N1i{φµλevi + (1− p)(1− φ)}N2i{p(1− φ)}N3i, (4)
and the marginal likelihood becomes
L(φ, λ, σ2) ∝
M∏
i=1
∫
vi
[
(φ− φµλevi)N1i{φµλevi + (1− p)(1− φ)}N2i{p(1− φ)}N3i
× 1
σ
exp
(
− vi
2
2σ2
)]
dvi.
(5)
As before, the maximum likelihood estimators of (φ, λ, σ2) can be obtained by maxi-
mizing the approximated marginal likelihood. In the current formulation (4), we assume
the same p across communities. This is often done in practice in part due to the lack of
accurate information on community-specific p. However, if such information is available,
these can be incorporated by modifying the conditional likelihood as Li(φ, λ|vi) ∝ (φ −
φµλevi)N1i{φµλevi + (1− pi)(1− φ)}N2i{pi(1− φ)}N3i, and inference can proceed similarly.
2.2.4 Implementation. The proposed random effects model can be implemented in the
SAS procedure NLMIXED (Kuss and McLerran, 2007; SAS Institute Inc., 2015). Adaptive
Gaussian Quadrature method (Pinheiro and Bates, 1995) can be used to approximate the
integral in (5). Sample codes for implementation are provided in the Web Appendix E.
Maximum likelihood estimators (φ̂, λ̂, σ̂2) and their corresponding standard errors from
the final Hessian matrix are displayed as a part of the standard output. The estimated
incidence rate of the ith community is λ̂ebvi, where v̂i is the empirical Bayes estimate of
the random effects vi. The overall incidence can be estimated as λ̂
∗ =
∑M
i=1 λ̂e
bvi/M , and
the variance of the overall incidence can be estimated as V̂ar(λ̂∗) =
{∑M
i=1 V̂ar(λ̂e
bvi) +
2
∑
16i<j6M Ĉov(λ̂e
bvi, λ̂ebvj)
}
/M2, where Ĉov(λ̂ebvi, λ̂ebvj) = V̂ar(λ̂)e
cσ2. In addition, the between-
community variability in true incidence rates can be estimated as τ̂ 2 = λ̂2(e2
cσ2 − ecσ2).
2.2.5 Extensions of the Random Effects Model. The proposed random effects model can
be extended to incorporate more complicated situations, including accounting for nested
structures with more than two levels, incorporating random components in prevalence, and
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estimating HIV incidence over time. Below we present the conditional likelihood correspond-
ing to each case. Subsequent inferences are similar as described before.
When observations are obtained on subjects from communities, which are further nested
within different sites, the conditional likelihood of community i can be written as
Li(j)(φ, λ|vj, vi(j)) ∝
(
φ− φµλevj+vi(j))N1i{φµλevj+vi(j) + (1− p)(1− φ)}N2i{p(1− φ)}N3i ,
where vj are “site effects”, j = 1, . . . , J , and vi(j), i = 1, . . . ,Mj, are the “community effects”
that are nested within vj. We assume vj ∼ N(0, σ2j ), and vi(j) ∼ N(0, σ2i ).
To incorporate varying prevalences across communities, the conditional likelihood becomes:
Li(φ, λ|vi, wi) ∝ {φewi(1− µλevi)}N1i{φµλevi+wi + (1− p)(1− φewi)}N2i{p(1− φewi)}N3i ,
where
(
vi
wi
)
∼ N
((
0
0
)
,
(
σ21 σ12
σ12 σ
2
2
))
.
Finally, suppose that the dataset consists of a series of cross-sectional data over time, the
conditional likelihood based on each round of data collection is:
Li(φ, λ|ti) ∝ (φ− φµλeti)N1i{φµλeti + (1− p)(1− φ)}N2i{p(1− φ)}N3i ,
where ti ∼ N(0, σ2) is the round-specific random effects.
2.3 A Permutation Test
In this section, we propose a permutation test for the null hypothesis of no heterogeneity
in incidence across communities, which is equivalent to testing the random effects variance
component being 0, H0 : σ
2 = 0 versus H1 : σ
2 > 0. Although it is natural to consider
a likelihood ratio test (LRT) by comparing the likelihood maximized under H0 and that
maximized without restrictions, in the current setting, the usual regularity condition that
the null value is in the interior of the parameter space does not hold and the distribution of
the LRT statistic under the null is no longer χ2 and is hard to derive.
Let N+ =
∑M
i=1Ni denote the total number of observations and for each individual, let
Cik and Sik denote the community membership index and the HIV infection state for i =
https://biostats.bepress.com/harvardbiostat/paper213
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1, . . . ,M, and k = 1, . . . , Ni. LetC = (C11, C12, . . . , CM,NM )
T and S = (S11, S12, . . . , SM,NM )
T
denote the vector of community membership indices and the vector of HIV infection states,
respectively. LetDobs = (Cobs,S) denote the observed data matrix andD` = (C`,S) denote a
permuted data matrix, where C` denotes a permutation ofC. When there is no heterogeneity
in incidence and prevalence across communities, an individual’s infection state confers no
information about his/her community membership and he/she can be equally likely to come
from any of the communities. We have Cik ⊥ Sik, where we use ⊥ to denote “is independent
of”. That is, the community indices can be viewed as random labels. This allows us to
permute the vector of community indices, resulting in permuted datasets D` that are equally
likely as the observed dataset. Under the null hypothesis H0, Pr
{
D = D` | C p= Cobs,D =
(Cobs,S)
}
= 1/N+!, where we use “
p
=” to denote “is a permutation of”. That is, the observed
data matrix, Dobs, can be viewed as a randomly selected element from the set
∏
consisting
of N+! matrices D
`. It follows that if T = T (D) is a test statistic, for example, the usual
LRT statistic T = −2(`MLσ2=0 − `MLσ2>0), the observed value T (Dobs) can be viewed under
H0 as a random sample of size 1 from the resulting permutation distribution of values{
T (D`) | D` ∈∏}. This provides the basis for valid inferences about H0.
The p-value is the proportion of test statistics calculated from permuted datasets that
are more extreme than the observed test statistic under H0. The total number of possible
permutations is usually too large to enumerate all. In practice, we take a random sample of
Q permutations, and approximate the p-value by 1 +
∑Q
q=1 I
{
T (Dq) > T (Dobs)
}
/(1 + Q),
where I(.) is the indicator function. We add 1 to both the numerator and denominator to
account for the fact that the observed dataset is also considered as one possible permutation.
2.4 The Coefficient of Variation (CV)
The random effects model described in Section 2.2 provides a natural way to estimate the
CV, defined as the between-cluster standard deviation τ divided by the overall incidence
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λ∗. Under the Lognormal model, the CV for incidence can be expressed as CV = τ/λ∗ =√
λ2(e2σ2 − eσ2)/(λeσ2/2) =
√
eσ2 − 1. An estimate of the CV is given by ĈV =
√
e
cσ2 − 1,
and an estimate of the asymptotic variance of ĈV can be computed using the delta method,
V̂ar(ĈV ) =
e2
cσ2 × V̂ar(σ̂2)
4(e
cσ2 − 1)
. (6)
When the variability of incidences across communities is extremely small, an estimate of
Var(σ̂2) may not be available in the SAS output, so we are not able to estimate Var(ĈV )
using (6). Alternatively, we consider two commonly used bootstrap strategies for clustered
data (Davison and Hinkley, 1997). One is the “cluster bootstrap”, where we randomly sample
M communities with replacement, and for each selected community, all individuals within
that community are included in the bootstrap sample (Field and Welsh, 2007). The other
is the “subject bootstrap”, where for each community i, i = 1, . . . ,M , we draw a bootstrap
sample of Ni subjects with replacement from the original sample (Roberts and Fan, 2004).
When the number of communities is relatively small, but community sizes are relatively
large, the “subject bootstrap” approach is usually preferred; for the settings involving a large
number of communities with small sizes, “cluster bootstrap” may work better. In addition,
“subject bootstrap” ensures that the total number of subjects remain the same as in the
original sample; while “cluster bootstrap” may lead to varying total sample sizes and the
difference in total sample sizes between a bootstrap sample and the original sample can be
large depending on the heterogeneity in community sizes in the original sample.
3. Simulation Studies
3.1 Fixed Effects Model vs. Random Effects Model
We conducted simulation studies to evaluate the performance of the proposed methods. Data
was simulated from a multinomial distribution with state-specific prevalence p1i = φ−φµλevi ,
p2i = φµλe
vi + (1 − p)(1 − φ), and p3i = p(1 − φ), where vi i.i.d∼ N(0, σ2), for i = 1, . . . ,M.
We assumed that the mean window period µ is 0.5 years, and the prevalence of long-term
https://biostats.bepress.com/harvardbiostat/paper213
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infection, 1 − φ = 0.25 throughout. We considered combinations of λ = 0.01, 0.03, or 0.05,
and σ = 0.1, 0.3, or 0.5 when (M,Ni) = (30, 500), or (20, 300).
[Table 1 about here.]
Table 1 summarizes the simulation results when the false recency rate is 0 (p = 1).
Additional results for scenarios based on a false recency rate of 2%, varying community
sizes, and sample size (M,Ni) settings similar to the Project ACCEPT are included in the
Web Appendix C (S-Tables 1-3). Under all scenarios, the average of λ̂∗ are close to the
truth for both models. When heterogeneity is small, both models achieve coverage rates that
are close to the nominal level, with a slight increase in the width of the confidence interval
from the random effects model. However, when heterogeneity is large, the actual coverage
of the fixed effects model can be substantially lower than the nominal level due to severe
underestimation of the standard errors. In contrast, confidence intervals based on the random
effects model provide the empirical coverage at or close to the nominal level in all settings.
To examine the robustness to the mis-specification of the random effects distribution, we
generated data under the same settings except that the random effects distribution was set
to be Gamma or Weibull. The Lognormal model continues to provide accurate estimates
of λ∗ and leads to confidence intervals with coverage close to the nominal level (S-Table
4; Web Appendix C). We assessed the performance of the proposed random effects model
in estimating community-specific incidences (Figure 2). Compared to the standard method,
the results from the random effects model are associated with substantially smaller Mean
Squared Errors (MSE) in all settings. The reduction in MSE is more substantial when there
is a larger heterogeneity in community sizes (S-Figure 2; Web Appendix C).
[Figure 2 about here.]
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3.2 Empirical Estimates of the Type I Error and Power for the Permutation Test
We evaluated the performance of the permutation test using similar data generation processes
as before. We set σ2 = 0 to examine the type I error rate and varied σ2 from 0.2 to 0.8 to
assess the power (S-Figure 3; Web Appendix C). In general, the empirical type I error
estimates of the proposed permutation test are very close to the nominal level of 0.05. The
power increases as σ, M , or Ni, increases. For fixed σ and (M ,Ni), the power is higher for
larger incidence.
3.3 The Coefficient of Variation
We next carried out simulation studies to assess the performance of the proposed CV
estimator under the same settings as in Section 3.1 (Table 2).
[Table 2 about here.]
In line with the expectation that accurate estimation of CV requires a relatively large number
of communities, the proposed estimator performs better in the settings where (M,Ni) =
(30, 500) than those with (M,Ni) = (20, 300): the average values of ĈV are in closer
agreement with their true counterparts, and the standard errors of the estimates are smaller.
In the settings we examined, the proposed estimator tends to underestimate the true CV.
This underestimation becomes smaller as sample size increases, indicating that this might
be a finite sample problem. When (M,Ni) = (20, 300) and the overall incidence λ
∗ is small
(λ∗ ≈ 1%), we were not able to estimate standard errors of ĈV due to the instability of
estimates for σ. For other settings, among the three methods of standard error estimation,
the delta method generally performs well for large τ . Both bootstrap approaches tend to
underestimate the true variability of ĈV with the “subject bootstrap” method outperforming
the “cluster bootstrap” approach. In contrast, when τ is small, bootstrap methods provide
more reliable standard error estimates than the delta method. When both λ∗ and τ are small,
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the standard error estimates based on the “cluster bootstrap” approach are closer to the true
sampling variability compared to those obtained from the “subject bootstrap” approach.
The confidence intervals in Table 2 were obtained using the standard formulae ĈV ±1.96×
ŜE(ĈV ). We also evaluated other bootstrap confidence intervals: the bootstrap percentile
confidence intervals, bootstrap pivotal confidence intervals, as well as one obtained by first
constructing a confidence interval based on log(ĈV ) and then exponentiating the endpoints.
Results suggest that the standard symmetric confidence intervals perform the best with the
coverage rates closest to the nominal level.
4. Estimating Overall and Community-Specific Incidences in Project ACCEPT
We applied the proposed methods to the data from the NIMH Project ACCEPT (HPTN
043) (Coates et al., 2014). This is a phase III, community-randomized trial conducted in
34 communities at four sites in Africa (Soweto and Vulindlela, South Africa; Tanzania; and
Zimbabwe). The primary endpoint, HIV incidence, was estimated from a cross-sectional
sample via a multi-assay algorithm (MAA) to identify recent infections. The MAA applied
in this study used four biomarkers: two serologic biomarkers (the BED-CEIA and an avidity
assay) and two non-serologic biomarkers (CD4 cell count and HIV viral load), and the mean
window period of this MAA was estimated to be 259 days (µ = 0.71 years) (Laeyendecker
et al., 2013a). Each study sample was initially characterized based on the results of the two
HIV rapid tests performed in-country, and those who had at least one reactive HIV rapid
test results were further tested using MAA at the HPTN Network Laboratory. Each study
participant’s HIV infection state can subsequently be classified as HIV-uninfected, recent
infection, or long-term infection (Table 3 (a)) (Laeyendecker et al., 2013b).
The estimated overall HIV incidence at each site and the associated uncertainty were
calculated using the standard fixed effects model, the two-level random effects model (con-
sidered individuals as level-1 units, communities as level-2 clusters) stratified by the site, and
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the three-level random effects model (considered individuals as level-1 units, communities
as level-2 clusters, and sites as level-3 clusters) (Table 3 (b)). In addition, we performed
the proposed permutation test and estimated the CV across multiple communities within
each site based on the two-level random effects model. As in Laeyendecker et al. (2013b), we
assumed a false recency rate of 0 (p = 1) in the Project ACCEPT study population, since the
MAA used in this study has been shown to reduce the misclassification rates substantially
and to provide accurate incidence estimates (Laeyendecker et al., 2012, 2013a; Brookmeyer
et al., 2013a,b; Eshleman et al., 2013). Additional sensitivity analysis results based on varying
the false recency rate from 1% to 5% are presented in the Web Appendix D (S-Table 5).
[Table 3 about here.]
We observed a strong heterogeneity across community-specific incidences at site Soweto:
The CV was substantial (estimated to be 0.742), and the p-value associated with the permu-
tation test for σ2 = 0 indicates strong evidence against the null (p = 0.005). The uncertainty
of the overall incidence estimate was substantially underestimated using the standard fixed
effects model. For the other three sites, both the CV and the permutation test p-value
suggested modest heterogeneity. In these cases, the underestimation of uncertainty was
minimal, and the standard model appeared to be adequate although using the random effects
model only led to minimal efficiency loss. For all sites, the estimates of the overall incidence
and its variability were almost identical regardless of the parametric assumptions about the
random effects distribution (S-Table 6; Web Appendix D).
For the estimation of SE(ĈV ), we presented estimates obtained using three different
approaches, except for the site Tanzania, where SE(ĈV ) cannot be estimated using the
delta method due to the extremely small variability in incidence rates across communities.
Here we would prefer “subject bootstrap” over “cluster bootstrap” because the number of
communities was relatively small, whereas the community sizes were large (28 out of 34
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communities with Ni > 1000). All methods led to the same conclusions, consistent with the
permutation test results.
[Figure 3 about here.]
Community-specific incidence estimates are presented in Figure 3. The community-specific
incidence rates estimated from random effects models were associated with shorter confidence
intervals compared to the standard method using information from that community only.
The point estimates for site-specific incidences from the two-level and the three-levelmodels
were virtually identical; but the three-level model led to larger standard errors for three of
the four site-specific incidence estimates and larger or similar standard errors for community-
specific incidence estimates in general. This may due to the fact that the number of sites
was relatively small and also that the additional assumption made about the distribution
of site-specific incidences in the three-level model may be questionable given that the site
Vulindlela appeared to be substantially different from the other three sites.
5. Discussion
In this paper, we develop a random effects model to estimate the overall and community-
specific HIV incidence from a cross-sectional design. In the presence of heterogeneity in
community-specific incidences, standard methods ignoring heterogeneity can lead to con-
siderable biased inference because ignoring between-community heterogeneity leads to an
underestimation of the uncertainty around the overall incidence estimate, while the proposed
random effects model adequately accounts for this uncertainty. When the heterogeneity
is negligible, the realized sample resembles an independent random sample, the standard
method for estimating the overall incidence works well as expected; the random effects model
yields similar results with minimal loss in efficiency because in such settings, the random
effects model produces an estimate of between-cluster heterogeneity close to 0.
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The random effects model leads to more efficient community-specific incidence estimates
than applying the standard method to data from each community because it pools informa-
tion from all communities. Assuming that the prevalence is constant across communities, we
propose a permutation test for the null hypothesis of no heterogeneity in community-specific
incidences. This test is easy to implement and its validity does not rely on parametric
assumptions. The random effects model provides a natural way to estimate the CV, an
essential parameter in the design and analysis of cluster randomized trials.
Our random effects model assumes a parametric distribution for the random effects. Both
simulation studies and real data analysis suggest that the random effects model is robust to
the mis-specification of the random effects distribution, when commonly-used distributions
for positive-valued random variables such as Lognormal, Gamma and Weibull are specified
because the shape of these distributions can be made similar by choice of parameter values.
The proposed method can account for the false recency rate (assumed to be known),
multi-level clustering, or varying prevalences across communities. While the false recency
rate does not affect the comparative conclusions between the random and the fixed effects
model, reliable cross-sectional incidence estimation requires accurate knowledge of the false
recency rate. The proposed model is also applicable to other settings with correlated data,
e.g., a series of cross-sectional data are collected over time. Extensions to incorporate tem-
poral dependence in incidence are possible through the modification of the random effects
distribution: instead of assuming λi’s are independently distributed, we can consider the joint
distribution of (λ1, . . . , λM ) with a more complex correlation structure (e.g., autoregressive
or banded Toeplitz).
6. Supplementary Materials
Web Appendices referenced in Sections 1-4 and sample codes for implementing the proposed
method are available with this article at the Biometrics website on Wiley Online Library.
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Figure 1. Contour plot of the actual coverage of 95% confidence intervals for the overall
incidence across 30 communities (500 individuals in each community) ignoring heterogeneity,
for varying incidences (horizontal axis) and heterogeneity across communities represented as
the standard deviation across community-specific incidences (vertical axis). Different colors
indicate whether or not the nominal coverage is attained with dark red representing the
situations where the nominal coverage is attained. Results are based on 1000 experiments.
Additional results on the generation of this figure are included in the Web Appendix A.
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Figure 2. Boxplots for the bias (
∑M
i=1(λ̂i − λi)/M) and the Mean Squared Errors (MSE)
(
∑M
i=1(λ̂i−λi)2/M) when estimating the community-specific incidences λi using the standard
method and the proposed method, based on 1000 simulations. Data generated under
Lognormal random effects model with µ = 0.5 years, p = 1, and φ = 0.75.
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Figure 3. Point estimates and 95% confidence intervals of community-specific HIV in-
cidences of 34 Project ACCEPT communities, using the standard method, the two-level
random effects model, and the three-level random effects model.
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Table 1
Simulation results for the standard fixed effects model vs. the proposed random effects model, with µ = 0.5 years, p = 1, φ = 0.75, and varying incidences.
Estimation based on assuming the random effects follow the Lognormal distribution. λ∗ and τ denote the overall incidence and the between-community standard
deviation. bE(bλ∗) anddSE(bλ∗) denote average and standard error of estimates from 1000 simulations. bE(bs) denotes average of likelihood-based estimates of the
standard error from the 1000 experiments. Coverage denotes the proportion of simulations in which the true λ∗ is contained in the nominal 95% confidence interval
(CI), and width refers to the mean width of the nominal 95% CI.
Standard Method (Fixed Effects Model) Proposed Method (Random Effects Model)
λ σ λ∗ τ Ê(λ̂∗) ŜE(λ̂∗) Ê(ŝ) Coverage Width Ê(λ̂∗) ŜE(λ̂∗) Ê(ŝ) Coverage Width
(%) (%) (%) (%) (%) (%) (%) (%) (%) (%) (%) (%) (%)
M = 30, Ni = 500
1 0.1 1.0 0.1 1.0 0.13 0.13 95.6 0.5 1.0 0.14 0.15 95.2 0.6
1 0.3 1.1 0.3 1.0 0.15 0.14 91.9 0.5 1.0 0.15 0.17 94.6 0.7
1 0.5 1.1 0.6 1.1 0.18 0.14 88.0 0.6 1.1 0.18 0.21 96.5 0.8
3 0.1 3.0 0.3 3.0 0.23 0.23 95.4 0.9 3.0 0.24 0.26 95.9 1.0
3 0.3 3.1 1.0 3.1 0.30 0.23 87.7 0.9 3.1 0.28 0.32 96.1 1.3
3 0.5 3.4 1.8 3.4 0.43 0.24 72.5 1.0 3.4 0.41 0.44 95.4 1.7
5 0.1 5.0 0.5 5.0 0.30 0.29 94.1 1.2 5.0 0.31 0.33 95.8 1.3
5 0.3 5.2 1.6 5.2 0.42 0.30 83.5 1.2 5.2 0.40 0.46 95.3 1.8
5 0.5 5.7 3.0 5.7 0.64 0.31 64.6 1.2 5.6 0.62 0.66 94.4 2.6
M = 20, Ni = 300
1 0.1 1.0 0.1 1.0 0.21 0.21 92.9 0.8 1.0 0.21 0.25 96.4 1.0
1 0.3 1.1 0.3 1.1 0.22 0.21 92.7 0.8 1.0 0.22 0.27 95.6 1.1
1 0.5 1.1 0.6 1.1 0.27 0.22 87.8 0.9 1.1 0.27 0.31 93.7 1.2
3 0.1 3.0 0.3 3.0 0.37 0.36 93.7 1.4 3.0 0.38 0.41 95.0 1.6
3 0.3 3.1 1.0 3.2 0.44 0.37 92.6 1.5 3.1 0.43 0.47 95.5 1.9
3 0.5 3.4 1.8 3.4 0.56 0.38 83.6 1.5 3.3 0.56 0.62 94.3 2.4
5 0.1 5.0 0.5 5.0 0.46 0.47 95.0 1.8 5.0 0.46 0.53 96.9 2.1
5 0.3 5.2 1.6 5.2 0.61 0.47 87.4 1.9 5.2 0.61 0.65 94.5 2.6
5 0.5 5.7 3.0 5.6 0.84 0.49 74.4 1.9 5.6 0.85 0.89 93.7 3.5
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Table 2
Simulation results for the coefficient of variation (CV) estimator based on the Lognormal random effects model, with µ = 0.5 years, p = 1, φ = 0.75, and varying
incidences. λ∗ and τ denote the overall incidence and the between-community standard deviation. bE(dCV ) anddSE(dCV ) denote average and standard error of
estimates from 1000 simulated studies. bE(bs) refers to the mean of estimates of the standard error from the 1000 experiments, and coverage denotes the proportion
of simulations in which the true CV is contained in the nominal 95% confidence interval. Non-NA represents the proportion of experiments in which the standard
error of CV estimates can be calculated using the delta method. Estimates of the standard errors and the actual coverage of the 95% confidence intervals were
obtained using three different approaches: the “cluster bootstrap”, the “subject bootstrap”, and the delta method. For the two bootstrap methods, we took 500
bootstrap replications.
Cluster Bootstrap Subject Bootstrap Delta Method
λ σ λ∗ τ CV Ê(ĈV ) ŜE(ĈV ) Ê(ŝ) Coverage Ê(ŝ) Coverage Ê(ŝ) Coverage Non-NA
(%) (%) (%) (%) (%) (%) (%)
M = 30, Ni = 500
1 0.1 1.0 0.1 0.100 0.137 0.184 0.212 98.7 0.275 100.0 0.427 95.8 42.8
1 0.3 1.1 0.3 0.307 0.248 0.237 0.224 96.4 0.287 100.0 0.355 100.0 63.9
1 0.5 1.1 0.6 0.533 0.475 0.253 0.256 87.8 0.324 91.1 0.278 100.0 89.9
3 0.1 3.0 0.3 0.100 0.091 0.114 0.103 93.7 0.117 96.5 0.195 94.0 46.9
3 0.3 3.1 1.0 0.307 0.271 0.133 0.104 84.4 0.116 88.2 0.151 99.7 91.3
3 0.5 3.4 1.8 0.533 0.495 0.136 0.119 88.6 0.125 91.2 0.136 94.0 99.6
5 0.1 5.0 0.5 0.100 0.085 0.090 0.076 92.7 0.085 96.6 0.152 96.3 56.2
5 0.3 5.2 1.6 0.307 0.280 0.101 0.075 85.3 0.082 89.6 0.095 99.6 97.0
5 0.5 5.7 3.0 0.533 0.505 0.115 0.094 84.7 0.090 86.3 0.112 91.4 100.0
M = 20, Ni = 300
1 0.1 1.0 0.1 0.100 0.192 0.304 —— —— —— —— —— —— 37.8
1 0.3 1.1 0.3 0.307 0.248 0.346 —— —— —— —— —— —— 46.4
1 0.5 1.1 0.6 0.533 0.444 0.403 —— —— —— —— —— —— 67.8
3 0.1 3.0 0.3 0.100 0.125 0.162 0.169 96.2 0.214 99.7 0.349 96.5 46.1
3 0.3 3.1 1.0 0.307 0.241 0.198 0.182 81.9 0.219 99.8 0.267 100.0 70.9
3 0.5 3.4 1.8 0.533 0.464 0.235 0.217 86.2 0.237 90.0 0.229 100.0 93.0
5 0.1 5.0 0.5 0.100 0.096 0.123 0.120 94.4 0.149 98.7 0.253 97.0 46.1
5 0.3 5.2 1.6 0.307 0.250 0.163 0.131 79.7 0.148 85.7 0.181 99.8 82.7
5 0.5 5.7 3.0 0.533 0.488 0.173 0.152 87.6 0.159 90.9 0.171 96.1 98.8
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Sample classification and analysis results of Project ACCEPT cross-sectional incidence data at each African site.
Soweto Tanzania Vulindlela Zimbabwe
(a). Sample classification.
M : Number of communities 8 10 8 8
N1: Uninfected 11962 8505 8197 10348
N2: Recent infections 101 47 230 67
N3: Long-term infections 1547 479 3400 1461
(b). Analysis results.
Standard fixed effects model
λ̂∗: Overall incidence by the standard model (%) 1.2 0.8 3.8 0.9
ŜE(λ̂∗): Variability of the standard incidence estimate (%) 0.12 0.11 0.25 0.11
Two-level random effects model
λ̂∗: Overall incidence by the two-level model (%) 1.3 0.8 3.8 0.9
ŜE(λ̂∗): Variability of the two-level incidence estimate (%) 0.34 0.11 0.30 0.14
Permutation test p-value 0.005 >0.99 0.27 0.17
ĈV : Coefficient of variation 0.7420 0.0001 0.0631 0.1872
ŜEdelta(ĈV ): Variability of ĈV by delta method 0.310 —— 0.157 0.207
ŜEcluster(ĈV ): Variability of ĈV by cluster bootstrap 0.282 0.076 0.072 0.142
ŜEsubject(ĈV ): Variability of ĈV by subject bootstrap 0.237 0.208 0.098 0.180
Three-level random effects model
λ̂∗: Overall incidence by the three-level model (%) 1.2 0.8 3.8 0.9
ŜE(λ̂∗): Variability of the three-level incidence estimate (%) 0.20 0.15 0.53 0.17
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Web Appendix A: Details on the Generation of Figure 1
In this section, we clarify details on how Figure 1 (contour plot) in the main paper was produced. We
assumed there were 30 communities (M = 30), and each community had 500 individuals (Ni = 500). The
false recency rate was set to 0 (p = 1), and the mean window period µ was 0.5 years. We calculated the
coverage of 95% confidence intervals for the overall incidence across 30 communities under the fixed effects
model (ignoring heterogeneity), for varying incidences and heterogeneity across communities. Specifically,
we considered a grid of incidence values (λ∗) from 1% to 7% at an increment of ∆λ∗ = 0.1%, and the
variability of overall incidence (represented as the variance: τ 2) from 0.0001% to 0.05% at an increment
of ∆τ 2 = 0.001%. For each combination of incidence and its variability, we calculated λ and σ based on
λ∗ = λeσ
2/2 and τ 2 = λ2(e2σ2−eσ2), and generated data under the corresponding λ and σ in the same way
as described in Section 3.1. The coverage was calculated as the proportion of simulations in which the
true incidence λ∗ was contained in the nominal 95% confidence interval, based on 1000 simulation runs.
In Figure 1, the horizontal axis is the overall incidence λ∗, and the vertical axis is the heterogeneity across
communities (represented as the standard deviation: τ). Different colors indicate the actual coverage of
95% confidence intervals obtained based on the fixed effects model ignoring heterogeneity, where dark
red represents the situations where the nominal coverage is achieved.
1
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Web Appendix B: Graphical Representation of Models
(a) Three-state longitudinal model of HIV seroconversion and subsequent reactivity to biomarkers of recent infection.
(b) Four-state longitudinal model in which a proportion, 1− p, of infected persons would be classified as “recently infected”
indefinitely.
S-Figure 1. Graphical representation of models.
Web Appendix C: Additional Simulation Results
We present additional simulation results in this section. In S-Table 1, we show the performance of the
proposed random effects model when p = 0.98 (false recency rate = 2%). Simulation settings were the
same as those described in Section 3.1 of the main paper, except that the false recency rate was no longer
assumed to be 0.
S-Table 2 corresponds to the setting with varying community sizes. We considered the case where
λ = 0.03, σ = 0.5 (CV = 0.533), µ = 0.5 years, p = 1, and φ = 0.75. Instead of assuming equal community
2
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Ê
(ŝ
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S-Table 2
Simulation results for the standard fixed effects model vs. the proposed random effects model under set-
tings with unequal cluster sizes generated from the discrete uniform distribution U{a, b}, with λ = 0.03,
σ = 0.5, µ = 0.5 years, p = 1, and φ = 0.75. Estimation based on assuming the random effects
follow the Lognormal distribution. Ê(λ̂∗) and ŜE(λ̂∗) denote average and standard error of estimates
from 1000 simulations. Ê(ŝ) denotes average of likelihood-based estimates of the standard error from the
1000 experiments. Coverage denotes the proportion of simulations in which the true λ∗ is contained in
the nominal 95% confidence interval (CI), and width refers to the mean width of the nominal 95% CI.
Fixed Effects Model Random Effects Model
M Ni Ê(λ̂
∗) ŜE(λ̂∗) Ê(ŝ) Coverage Width Ê(λ̂∗) ŜE(λ̂∗) Ê(ŝ) Coverage Width
(%) (%) (%) (%) (%) (%) (%) (%) (%) (%)
λ∗ = 3.4%, τ = 1.8%
10 U{500, 2000} 3.4 0.68 0.27 57.2 1.1 3.4 0.65 0.62 91.4 2.4
20 U{200, 400} 3.4 0.57 0.38 80.4 1.5 3.3 0.56 0.61 93.9 2.4
20 U{50, 550} 3.4 0.57 0.37 79.7 1.5 3.3 0.54 0.61 94.4 2.4
30 U{100, 900} 3.4 0.44 0.25 72.2 1.0 3.3 0.43 0.47 94.3 1.8
sizes, Ni were generated from the discrete uniform distribution U{a, b}. We examined the following
scenarios of (M,Ni): (10,U{500, 2000}), (20,U{200, 400}), (20,U{50, 550}), and (30,U{100, 900}).
We also performed simulation studies under sample size settings similar to the Project ACCEPT
(S-Table 3). Specifically, we considered (M,Ni) = (10, 1500), corresponding to settings with fewer
communities and larger number of individuals per community. We simulated data under three different
scenarios, mimicking situations of Soweto, Vulindlela, and Zimbabwe, respectively (in terms of the overall
incidence, λ∗, and heterogeneity of incidence, τ).
1. Soweto: small incidence with large between-community heterogeneity.
2. Vulindlela: large incidence with small between-community heterogeneity.
3. Zimbabwe: small incidence with small between-community heterogeneity.
4
Hosted by The Berkeley Electronic Press
S-Table 3
Simulation results for the standard fixed effects model vs. the proposed random effects model, with
(M,Ni) = (10, 1500), µ = 0.71 years, p = 1, and varying incidences. Estimation based on assum-
ing the random effects follow the Lognormal distribution. λ∗ and τ denote the overall incidence and the
between-community standard deviation. Ê(λ̂∗) and ŜE(λ̂∗) denote average and standard error of estimates
from 1000 simulations. Ê(ŝ) denotes average of likelihood-based estimates of the standard error from the
1000 experiments. Coverage denotes the proportion of simulations in which the true λ∗ is contained in
the nominal 95% confidence interval (CI), and width refers to the mean width of the nominal 95% CI.
Fixed Effects Model Random Effects Model
λ∗ τ Ê(λ̂∗) ŜE(λ̂∗) Ê(ŝ) Coverage Width Ê(λ̂∗) ŜE(λ̂∗) Ê(ŝ) Coverage Width
(%) (%) (%) (%) (%) (%) (%) (%) (%) (%) (%) (%)
M = 10, Ni = 1500
Setting: Soweto
1.2 0.92 1.3 0.31 0.11 55.6 0.4 1.2 0.31 0.29 90.4 1.1
Setting: Vulindlela
4.0 0.24 4.0 0.24 0.23 93.2 0.9 4.0 0.24 0.26 95.1 1.0
Setting: Zimbabwe
0.9 0.18 0.9 0.11 0.10 91.5 0.4 0.9 0.11 0.12 94.6 0.5
We investigated the robustness of the proposed model to the mis-specification of the random effects
distribution. We performed simulation studies under the same settings as described in Section 3.1 of
the main paper, except that the random effects distribution was assumed to be Gamma or Weibull.
Corresponding results are summarized in S-Table 4.
In addition, we assessed the performance of the proposed method in estimating community-specific
incidences and compared with the standard method under the settings where community sizes are un-
equal. Community sizes Ni were generated from the discrete uniform distribution U{a, b}. We examined
(M,Ni)=(20,U{50, 550}) and (M,Ni)=(30,U{100, 900}). Boxplots summarizing bias and Mean Squared
Errors (MSE) over 1000 simulations are displayed in S-Figure 2.
Simulation results for the empirical Type I error and power estimates of the proposed permutation
test for a 0.05 level test of the null hypothesis that there is no heterogeneity of incidence rates across
communities are shown in S-Figure 3.
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S-Figure 2. Boxplots for the bias (∑Mi=1(λ̂i−λi)/M) and the Mean Squared Errors (MSE) (∑Mi=1(λ̂i−λi)2/M)
when estimating the community-specific incidences λi using the standard method and the proposed method,
based on 1000 simulations. Data generated under Lognormal random effects model with µ = 0.5 years, p = 1,
and φ = 0.75. Community sizes generated under discrete uniform distributions.
7
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S-Figure 3. Simulation results for the empirical type I error and power estimates (expressed as percentages)
of the proposed permutation test for a 0.05 level test of the null hypothesis: no heterogeneity of incidence rates
across communities. Data generated under the Lognormal random effects model with µ = 0.5 years, p = 1, and
φ = 0.75. Results based on 1000 simulation runs and for each experiment, 2000 permutations were used for type
I error estimates and 1000 permutations were used for power estimates.
8
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Web Appendix D: Robustness of Project ACCEPT Analysis
Sensitivity analysis results based on varying the false recency rate from 1% to 5% in the Project ACCEPT
are presented in S-Table 5. We re-estimated the overall incidence and its variability assuming the false
recency rate to be 1%, 2%, 3%, 4%, and 5% for each site, except for site Zimbabwe, where the false
recency rate of 4% and 5% are inadmissible given the small number of recent infections identified.
S-Table 5
Sensitivity analysis results based on varying p in the Project ACCEPT data analysis. λ̂∗fixed and ŜE(λ̂∗fixed)
represent the overall incidence and its standard error by the standard model. λ̂∗random and ŜE(λ̂∗random) denote
the overall incidence and its standard error by the two-level random effects model. All results expressed in %.
1− p: False Recency Rate (%) 0 1 2 3 4 5
Site: Soweto
λ̂∗fixed 1.2 1.0 0.8 0.6 0.4 0.2
ŜE(λ̂∗fixed) 0.12 0.12 0.12 0.12 0.12 0.12
λ̂∗random 1.3 1.1 0.9 0.8 0.6 0.4
ŜE(λ̂∗random) 0.34 0.36 0.37 0.37 0.36 0.31
Site: Tanzania
λ̂∗fixed 0.8 0.7 0.6 0.5 0.4 0.4
ŜE(λ̂∗fixed) 0.11 0.11 0.11 0.11 0.11 0.11
λ̂∗random 0.8 0.7 0.6 0.5 0.4 0.4
ŜE(λ̂∗random) 0.11 0.11 0.11 0.11 0.11 0.11
Site: Vulindlela
λ̂∗fixed 3.8 3.3 2.7 2.1 1.5 0.9
ŜE(λ̂∗fixed) 0.25 0.25 0.25 0.25 0.25 0.26
λ̂∗random 3.8 3.3 2.7 2.1 1.5 0.8
ŜE(λ̂∗random) 0.30 0.31 0.31 0.33 0.35 0.39
Site: Zimbabwe
λ̂∗fixed 0.9 0.7 0.5 0.3 —— ——
ŜE(λ̂∗fixed) 0.11 0.11 0.11 0.11 —— ——
λ̂∗random 0.9 0.7 0.5 0.3 —— ——
ŜE(λ̂∗random) 0.14 0.15 0.16 0.18 —— ——
9
https://biostats.bepress.com/harvardbiostat/paper213
We also explored the robustness of the Project ACCEPT analysis results to different parametric
assumptions about the random effects distribution. For each site, we fit the two-level random effects
model assuming a Lognormal, Gamma or Weibull random effects distribution (S-Table 6). For all sites,
the overall incidence estimates and their standard errors are almost identical regardless of the random
effects distribution assumed.
S-Table 6
Robustness of data analysis to the random effects distributional assumption. λ̂∗ and ŜE(λ̂∗) denote the
overall incidence and its standard error by the two-level random effects model. All results expressed in %.
Lognormal Gamma Weibull
Site: Soweto
λ̂∗ 1.3 1.2 1.2
ŜE(λ̂∗) 0.34 0.31 0.30
Site: Tanzania
λ̂∗ 0.8 0.8 0.8
ŜE(λ̂∗) 0.11 0.11 0.11
Site: Vulindlela
λ̂∗ 3.8 3.8 3.9
ŜE(λ̂∗) 0.30 0.30 0.32
Site: Zimbabwe
λ̂∗ 0.9 0.9 0.9
ŜE(λ̂∗) 0.14 0.12 0.13
Web Appendix E: Sample SAS Codes
The proposed models can be implemented in SAS PROC NLMIXED (SAS Institute Inc., 2015). In E.1,
we provide sample codes for the Lognormal random effects model. The current SAS PROC NLMIXED
procedure only allows a normal distribution for the random effects vi (i.e., a Lognormal distribution
for the community-specific incidence λi = λevi). To implement the method for other random effects
distributions, we apply the probability integral transformation (Hoel et al., 1971; Nelson et al., 2006) and
10
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include sample codes in E.2 (Gamma) and E.3 (Weibull). We provide sample codes for implementing the
three-level random effects model in E.4 and describe the required program inputs in E.5.
E.1 Code for the Two-level Lognormal Random Effects Model
PROC NLMIXED data = &dataset TECH = NEWRAP;
parms lambda = &lambda_init phi = &phi_init sigma2 = &sigma2_init;
bounds lambda > 0, 0 < phi < 1, sigma2 >= 0;
lambda_i = lambda*exp(v_i);
if state = 1 then prob = phi-phi*&mu*lambda*exp(v_i);
if state = 2 then prob = phi*&mu*lambda*exp(v_i)+(1-&p)*(1-phi);
if state = 3 then prob = &p*(1-phi);
ll = log(prob);
model state ~ general(ll);
random v_i ~ normal(0,sigma2) subject = community;
predict lambda_i out = pred_comm_spec;
RUN;
E.2 Code for the Two-level Gamma Random Effects Model
PROC NLMIXED data = &dataset TECH = NEWRAP;
parms lambda = &lambda_init phi = &phi_init theta = &theta_init;
bounds lambda > 0, 0 < phi < 1, theta > 0;
lambda_i = lambda*w_i;
p_i = CDF('NORMAL',a_i);
if (p_i > 0.999999) then p_i = 0.999999;
w_i = quantile('GAMMA',p_i,1/theta,theta);
if state = 1 then prob = phi-phi*&mu*lambda*w_i;
if state = 2 then prob = phi*&mu*lambda*w_i+(1-&p)*(1-phi);
if state = 3 then prob = &p*(1-phi);
ll = log(prob);
model state ~ general(ll);
random a_i ~ normal(0,1) subject = community;
predict lambda_i out = pred_comm_spec;
RUN;
E.3 Code for the Two-level Weibull Random Effects Model
PROC NLMIXED data = &dataset TECH = NEWRAP;
parms lambda = &lambda_init phi = &phi_init theta = &theta_init;
bounds lambda > 0, 0 < phi < 1, theta > 0;
lambda_i = lambda*w_i;
p_i = CDF('NORMAL',a_i);
if (p_i > 0.999999) then p_i = 0.999999;
w_i = quantile('WEIBULL',p_i,theta,1);
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if state = 1 then prob = phi-phi*&mu*lambda*w_i;
if state = 2 then prob = phi*&mu*lambda*w_i+(1-&p)*(1-phi);
if state = 3 then prob = &p*(1-phi);
ll = log(prob);
model state ~ general(ll);
random a_i ~ normal(0,1) subject = community;
predict lambda_i out = pred_comm_spec;
RUN;
E.4 Code for Three-level Random Effects Model
PROC NLMIXED data = &dataset TECH = NEWRAP;
parms lambda = &lambda_init phi = &phi_init s1 = &s1_init s2 = &s2_init;
bounds lambda > 0, 0 < phi < 1, s1 >= 0 s2 >= 0;
lambda_1i = lambda*exp(v_1i);
lambda_2i = lambda*exp(v_1i+v_2i);
if state = 1 then prob = phi-phi*&mu*lambda*exp(v_1i+v_2i);
if state = 2 then prob = phi*&mu*lambda*exp(v_1i+v_2i)+(1-&p)*(1-phi);
if state = 3 then prob = &p*(1-phi);
ll = log(prob);
model state ~ general(ll);
random v_1i ~ normal(0,s1) subject = site;
random v_2i ~ normal(0,s2) subject = community(site);
predict lambda_1i out = pred_site_spec;
predict lambda_2i out = pred_comm_spec;
RUN;
E.5 Description of the Required Inputs in E.1-E.4
SAS programs in E.1-E.4 require the following macro variables from the user:
• dataset: the name of the input dataset.
– In E.1-E.3: a dataset with two columns (subjects’ community indices and HIV infection states).
– In E.4: a dataset with three columns (subjects’ site indices , subjects’ community indices, and
HIV infection states) where individuals are nested within communities and communities are
nested within sites.
• mu: a user-specified µ (estimated externally).
• p: a user-specified p (estimated externally).
12
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• lambda_init: the initial value for λ.
• phi_init: the initial value for φ.
• – sigma2_init in E.1: the initial value for σ2.
– theta_init in E.2 and E.3: the initial value for θ (the scale parameter in the Gamma distri-
bution/the shape parameter in the Weibull distribution).
– s1_init and s2_init in E.4: initial values for s1 and s2 (s1 is the variance component of
the Normal random effects at the site level, and s2 is the variance component of the Normal
random effects at the community level).
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